Alveolar Bone Mesenchymal Stem Cells Exhibit Osteogenic Potential with Fewer Macrophages
Journal of Bone Metabolism · 31.05.2025 · 32 (2) · 83-92
DOI: 10.11005/jbm.25.847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone Metabolism, erschienen am 31.05.2025. Verfasst von Zhao Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju, Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Korean Fund for Regenerative Medicine.
Abstract (Originalsprache)
Background
Mesenchymal stem cells (MSCs) derived from various tissues demonstrate regenerative potential in bone tissue engineering. However, bone marrow-derived MSCs (BMSCs) often contain macrophage contamination, necessitating additional purification steps such as liposomal clodronate treatment. In contrast, alveolar bone MSCs alveolar bone-derived MSCs (aBMSCs) may offer a distinct advantage due to their lower macrophage contamination.
Methods
The aBMSCs were isolated from alveolar bone fragments through enzymatic digestion, and their macrophage contamination was compared to BMSCs using flow cytometry for MSC surface markers (CD44, CD105, CD90.2, CD140a) and macrophage markers (CD11b).
Results
The aBMSCs exhibited significantly lower macrophage contamination compared to BMSCs and maintained osteogenic potential. Under inflammatory conditions in the presence of interleukin-1β (IL-1β), aBMSCs maintained their osteogenic capacity—unlike BMSCs, whose differentiation was impaired—accompanied by further activation of Protocadherin FAT4 (FAT4), which is known to initiate the osteogenic differentiation trajectory of aBMSCs.
Conclusions
These results highlight aBMSCs as a promising cell source for bone regeneration, offering low macrophage contamination and sustained osteogenic potential under inflammatory conditions such as IL-1β exposure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju, Korea.
- Hard-Tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Korean Fund for Regenerative Medicine
- Ministry of Health and Welfare
- Ministry of Education
Zitieren
APA
Wang, Z., Joun, J., Song, J. H., & Koh, J. T. (2025). Alveolar Bone Mesenchymal Stem Cells Exhibit Osteogenic Potential with Fewer Macrophages. Journal of Bone Metabolism, 32(2), 83-92. https://doi.org/10.11005/jbm.25.847
Vancouver
Wang Z, Joun J, Song JH, Koh JT. Alveolar Bone Mesenchymal Stem Cells Exhibit Osteogenic Potential with Fewer Macrophages. Journal of Bone Metabolism. 2025;32(2):83-92. doi:10.11005/jbm.25.847
BibTeX
@article{Wang2025,
author = {Wang, Zhao and Joun, Jaemin and Song, Ju Han and Koh, Jeong-Tae},
title = {Alveolar Bone Mesenchymal Stem Cells Exhibit Osteogenic Potential with Fewer Macrophages},
journal = {Journal of Bone Metabolism},
year = {2025},
volume = {32},
number = {2},
pages = {83--92},
doi = {10.11005/jbm.25.847}
}
EUVIMED